GAFA
TMO icon

Garton & Associates Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Garton & Associates Financial Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-397
Closed -$230K – 635
2025
Q4 		$230K Buy
+397
New +$225K 0.13% 123

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Garton & Associates Financial Advisors's TMO Position: Q1 2026 in Review

Garton & Associates Financial Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 397 shares — an estimated $230K sold.

Garton & Associates Financial Advisors first reported a position in TMO in Q4 2025 and held it in 1 quarter. The position peaked at $230K in Q4 2025. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Garton & Associates Financial Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Garton & Associates Financial Advisors sold 397 Thermo Fisher Scientific shares in Q1 2026, an estimated $230K.
  • Garton & Associates Financial Advisors first reported a position in Thermo Fisher Scientific in Q4 2025 and held it in 1 quarter.
  • Garton & Associates Financial Advisors's Thermo Fisher Scientific position peaked at $230K in Q4 2025.
  • 2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Garton & Associates Financial Advisors's 13F filing for Q1 2026, filed 11 May 2026.